末梢神経損傷の市場規模、シェア、成長分析、製品タイプ別、手術別、用途別、地域別 - 産業予測 2025-2032年

末梢神経損傷の世界市場規模は2023年に15億5,000万米ドルと評価され、2024年の16億6,000万米ドルから2032年には29億2,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは7.3％で成長する見通しです。

末梢神経損傷市場は、外傷関連傷害の有病率の上昇、神経修復・再生の技術進歩、高齢化によって急速に進化しています。手術手法や生体材料における最近の技術革新は、患者の転帰を著しく向上させ、市場拡大に寄与しています。さらに、神経刺激療法や神経調節療法の出現により、治療の選択肢が広がっています。学術機関、医療機器メーカー、研究機関の協力体制が、最先端のソリューション開発を後押ししています。しかし、高度な治療に伴う高額な費用や限られた償還制度などの課題も依然として残っています。市場各社はこうしたハードルに対処する一方で、末梢神経損傷管理における効果的なソリューションに対する需要の高まりを活用し、このダイナミックなヘルスケア分野での地位を確立しようとしています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 規制情勢
• ケーススタディ

末梢神経損傷市場規模：製品タイプ別& CAGR（2025-2032）

• 市場概要
• 神経導管
• 神経保護剤
• 神経コネクター
• 神経包帯

末梢神経損傷市場規模：手術別& CAGR（2025-2032）

• 市場概要
• 直接的な神経修復
• 神経移植
• 幹細胞療法

末梢神経損傷市場規模：用途別& CAGR（2025-2032）

• 市場概要
• 上肢
• 下肢

末梢神経損傷市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024年）

主要企業プロファイル

• Axogen Corporation（United States）
• Integra LifeSciences Holdings Corporation（United States）
• Medtronic plc（Ireland）
• Stryker Corporation（United States）
• Baxter International Inc.（United States）
• Polyganics BV（Netherlands）
• Smith & Nephew plc（United Kingdom）
• Boston Scientific Corporation（United States）
• Abbott Laboratories（United States）
• NeuroPace, Inc.（United States）
• Nuvectra Corporation（United States）
• OrthoPediatrics Corp.（United States）
• Zimmer Biomet Holdings, Inc.（United States）
• NeuroMetrix, Inc.（United States）
• MicroPort Scientific Corporation（China）
• Nihon Kohden Corporation（Japan）
• Natus Medical Incorporated（United States）
• LivaNova plc（United Kingdom）
• Bioventus LLC（United States）
• Renerva, LLC（United States）

結論と提言

Global Peripheral Nerve Injuries Market size was valued at USD 1.55 billion in 2023 and is poised to grow from USD 1.66 billion in 2024 to USD 2.92 billion by 2032, growing at a CAGR of 7.3% during the forecast period (2025-2032).

The peripheral nerve injuries market is evolving rapidly, fueled by the rising prevalence of trauma-related injuries, technological advances in nerve repair and regeneration, and an aging population. Recent innovations in surgical methodologies and biomaterials have markedly enhanced patient outcomes, contributing to market expansion. Additionally, the emergence of neurostimulation and neuromodulation therapies is broadening treatment alternatives. Collaborative efforts among academic institutions, medical device companies, and research organizations are driving the development of cutting-edge solutions. However, challenges persist, including the high costs associated with advanced treatments and limited reimbursement frameworks. As market players address these hurdles, they also seek to leverage growing demand for effective solutions in peripheral nerve injury management, positioning themselves within this dynamic segment of the healthcare landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Peripheral Nerve Injuries market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Peripheral Nerve Injuries Market Segments Analysis

Global Peripheral Nerve Injuries Market is segmented by Product Type, Surgery, Applications and region. Based on Product Type, the market is segmented into Nerve Conduit, Nerve Protector, Nerve Connector and Nerve Wraps. Based on Surgery, the market is segmented into Direct nerve repair, Nerve Grafting and Stem Cell Therapy. Based on Applications, the market is segmented into Upper Extremities and Lower Extremities. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Peripheral Nerve Injuries Market

The global peripheral nerve injuries market is significantly driven by the escalating occurrence of these injuries, which can result from trauma, accidents, sports-related incidents, and chronic ailments like diabetes. As the rates of peripheral nerve injuries continue to rise, there is an increasing need for effective treatment options and therapeutic solutions. This growing demand not only highlights the urgency for advanced medical interventions but also presents opportunities for healthcare providers and companies to innovate and enhance their offerings. As a result, addressing this prevalent issue is crucial for both patient outcomes and market expansion in the field of peripheral nerve injury management.

Restraints in the Global Peripheral Nerve Injuries Market

One of the significant constraints in the Global Peripheral Nerve Injuries market is the elevated cost associated with treatment. The expenses incurred for managing peripheral nerve injuries can be considerable, especially when surgeries, rehabilitation, and ongoing care are required. These high treatment costs can create barriers to accessing necessary medical services for certain patients, thereby hindering overall market growth. As many individuals may find it difficult to afford comprehensive treatment options, this financial burden poses a challenge to the expansion and accessibility of care within the market, limiting opportunities for both patients and healthcare providers.

Market Trends of the Global Peripheral Nerve Injuries Market

The Global Peripheral Nerve Injuries market is experiencing a notable trend driven by rapid technological advancements in nerve repair and regeneration techniques. Researchers and medical device firms are increasingly focused on developing innovative solutions, such as advanced nerve conduits, neurostimulation devices, and bioengineered materials, which significantly enhance treatment outcomes for nerve injuries. These cutting-edge technologies not only aim to improve nerve regeneration and expedite recovery times but also seek to reduce associated complications, thus fostering a growing demand for more effective and efficient treatment options in clinical practice. The integration of these advancements is set to shape the future landscape of the market positively.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies

Global Peripheral Nerve Injuries Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Nerve Conduit
• Nerve Protector
• Nerve Connector
• Nerve Wraps

Global Peripheral Nerve Injuries Market Size by Surgery & CAGR (2025-2032)

• Market Overview
• Direct nerve repair
• Nerve Grafting
• Stem Cell Therapy

Global Peripheral Nerve Injuries Market Size by Applications & CAGR (2025-2032)

• Market Overview
• Upper Extremities
• Lower Extremities

Global Peripheral Nerve Injuries Market Size & CAGR (2025-2032)

• North America (Product Type, Surgery, Applications)
  • US
  • Canada
• Europe (Product Type, Surgery, Applications)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Surgery, Applications)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Surgery, Applications)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Surgery, Applications)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Axogen Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integra LifeSciences Holdings Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Polyganics BV (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smith & Nephew plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeuroPace, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nuvectra Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OrthoPediatrics Corp. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zimmer Biomet Holdings, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeuroMetrix, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nihon Kohden Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Natus Medical Incorporated (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioventus LLC (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Renerva, LLC (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations